Clinical Trials Directory

Trials / Completed

CompletedNCT00941096

Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination

Efficacy Of The Bimatoprost/Timolol Fixed Combination In Patients Treated With Bimatoprost for Primary Open Angle Glaucoma, Exfoliation Glaucoma or Ocular Hypertension.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Larissa University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the ocular hypotensive effect of Bimatoprost and the potential additional effect of the Bimatoprost/Timolol fixed combination in eyes with ocular hypertension, primary open angle glaucoma or exfoliation glaucoma.

Conditions

Interventions

TypeNameDescription
DRUGBimatoprost and Bimatoprost/Timolol fixed combination.Following an appropriate wash-out period, participants were given a 5-week long treatment with Bimatoprost 0.03% once daily in the evening followed by a further 5-week long treatment with the Bimatoprost 0.03%/Timolol 0.5% fixed combination administered in the evening.

Timeline

Start date
2009-07-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2009-07-17
Last updated
2010-11-30

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT00941096. Inclusion in this directory is not an endorsement.